glp-1 type 2 diabetes drugs are all approved for glucose control in (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, and obesity. None GLP1 Receptor Agonists vs SGLT2-I

Compared to more frequent side effects like gastrointestinal issues and headaches, back pain is rare but should be monitored if experienced

A recent paper published in The Lancet showed that nearly 20% of participants in lifestyle interventions without medications gain weight, around 40% lose between 1-10% of their body weight, and just 13% lose more than 10%

They are not regulated and tested like prescription medications, meaning they may not be effective, could have unknown side effects, or contain hidden (and potentially dangerous) ingredients

Patients benefit from enhanced engagement and real-time monitoring, fostering adherence to treatment protocols and enabling a data-driven approach to long-term care

If fatigue persists beyond month 3 despite protein, sleep, hydration check thyroid, iron, D, B12

Most of these diseases are interrelated, with glycemic control and weight loss being a major factor in improving the overall health of sufferers